Eloralintide
A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity
Eli Lilly · Phase 1 · Recruiting · Enrollment 115
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Eloralintide | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |